NCT05424627View on ClinicalTrials.gov

Myeloid Derived Suppressor Cells in Systemic Lupus Erythematosus

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

July 15, 2026

Study Completion Date

January 15, 2027

Conditions
Systemic Lupus Erythematosus
Trial Locations (1)

54500

Thomas Moulinet, Vandœuvre-lès-Nancy

All Listed Sponsors
lead

Central Hospital, Nancy, France

OTHER

NCT05424627 - Myeloid Derived Suppressor Cells in Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter